经肝动脉介入治疗肝转移瘤的疗效影响因素  

Analysis of Curative Effect of Liver Metastasis Tumor with Transcatheter Hepatic Artery Interventional Therapy

作　　者：崔杰[1] 

机构地区：[1]陕西省安康市中心医院肿瘤内科,陕西安康725000

出　　处：《河北医学》2013年第11期1649-1651,共3页Hebei Medicine

摘　　要：目的:探讨分析影响经肝动脉介入治疗肝转移瘤的临床疗效的因素。方法:选取我院肿瘤科收治的肝转移瘤患者110例,采用肝动脉介入治疗肝转移瘤,并对可能的疗效影响因素进行多因素COX回归分析。结果:肝内转移瘤的数目、肝内转移瘤的血液供应情况、经过介入治疗后有无进行全身化疗、介入治疗之前是否有其他转移病灶以及原发的肿瘤的病理类型是经肝动脉介入治疗肝转移瘤的独立预后因素。结论:单发的肝内转移瘤、肝内转移瘤具有丰富的血液供应、介入治疗同时联合全身化疗、没有其他转移病灶以及原发的肿瘤的病理类型是影响经肝动脉介入治疗肝转移瘤取得良好治疗效果的主要因素。Objective： To investigate the curative effect of liver metastasis tumor with transeatheter hepatic artery interventional therapy. Method： 110 patients with liver metastasis tumor were selected in our hospital. They were all received transcatheter hepatic artery interventional therapy, and the multivariate COX analysis was applied for analyzing the possible factors. Result： The number of intrahepatic metastasis, the blood supply for liver metastasis tumor, systemic chemotherap y after interventional therapy, other metastatic after interventional therapy, and primary tumor pathological types were the independently predictive factors. Conclusion： Solitary intrahepatic metastases, rich blood supply for hepatic metastases,interventional therapy combined with systemic chemotherapy, no other metastatic lesions, pathological types are the main factors for the good therapeutic effect of liver metastasis and primary tumor tumors treated with hepatic artery interventional therapy.

关 键 词：肝转移瘤 介入治疗 肝动脉 COX多因素回归分析 

分 类 号：R735.7[医药卫生—肿瘤]